Intrathecal baclofen therapy improves functional intelligibility of speech in cerebral palsy

Clinical Rehabilitation

Volumn 20, Issue 3, 2006, Pages 228-231

  Leary, Siobhan M ^a   Gilpin, P ^a   Lockley, L ^a   Rodriguez, L ^a   Jarett, L ^a   Stevenson, V L ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BACLOFEN; DANTROLENE; GABAPENTIN;

ADULT; ARTICLE; CASE REPORT; CEREBRAL PALSY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DYSARTHRIA; FUNCTIONAL ASSESSMENT; HUMAN; LIMB PAIN; MALE; PAIN ASSESSMENT; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SPASTICITY; SPEECH INTELLIGIBILITY; SPEECH THERAPY;

ADULT; BACLOFEN; CEREBRAL PALSY; DYSARTHRIA; GABA AGONISTS; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MALE;

EID: 33645826903     PISSN: 02692155     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269215506cr940oa     Document Type: Article

References (12)

1. Penn RD, Kroin JS. Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1984; 1: 1078.
2. Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, Kroin JS. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989; 320: 1517-21.
3. Dralle D, Muller H, Zierski J, Klug N. Intrathecal baclofen for spasticity. Lancet 1985; 2: 1003.
4. Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991; 265: 1418-22.
5. Butler C, Campbell S. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. AACTDM Treatment Outcomes Committee Review Panel. Dev Med Child Neurol 2000; 42: 634-45.
6. Albright AL, Barry MJ, Shafton DH, Ferson SS. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 2001; 43: 652-7.
7. Bjornson KF, McLaughlin JF, Loeser JD, Nowak-Cooperman KM, Russel M, Bader KA, Desmond SA. Oral motor, communication, and nutritional status of children during intrathecal baclofen therapy: a descriptive pilot study. Arch Phys Med Rehabil 2003; 84: 500-506.
8. Jarrett L, Leary SM, Porter B et al. Managing spasticity in people with multiple sclerosis: a goal-oriented approach to intrathecal bactofen therapy. Int J MS Care 2001; 3: 2.
9. Mason C, Gilpin P, McGowan S, Rossiter D. The effect of intrathecal baclofen on functional intelligibility of speech. Int J Lang Commun Disord 1998; 33(suppl): 24-5.
10. Koman LA, Smith BP, Shilt JS. Cerebral palsy. Lancet 2004; 363: 1619-31.
11. Pennington L, Goldbart J, Marshall J. Speech and language therapy to improve the communication skills of children with cerebral palsy. Cochrane Database Syst Rev 2004; 2: CD003466.
12. Yorkston KM, Beukelman DR. Communication efficiency of dysarthric speakers as measured by sentence intelligibility and speaking rate. J Speech Hear Disord 1981; 46: 296-301.